Novan, Inc. - stock earnings
Stock symbol NOVN is outdated, potentially delisted? Maybe it is available on other exchange?
NOVN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -14.1 million USD | 3.2 million USD |
| 2022Q4 | -3.0 million USD | 10.5 million USD |
| 2022Q3 | -6.0 million USD | 5.1 million USD |
| 2022Q2 | -8.9 million USD | 6.2 million USD |
| 2022Q1 | -13.4 million USD | 1.9 million USD |
| 2021Q4 | -8.2 million USD | 655000 USD |
| 2021Q3 | -6.5 million USD | 737000 USD |
| 2021Q2 | -6.0 million USD | 747000 USD |
| 2021Q1 | -9.0 million USD | 819000 USD |
| 2020Q4 | -6.6 million USD | 1.1 million USD |
| 2020Q3 | -8.4 million USD | 1.3 million USD |
| 2020Q2 | -8.1 million USD | 1.3 million USD |
| 2020Q1 | -6.2 million USD | 1.2 million USD |
NOVN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -31.3 million USD | 23.7 million USD |
| 2021 | -29.7 million USD | 3.0 million USD |
| 2020 | -29.3 million USD | 4.9 million USD |
| 2019 | -30.4 million USD | 4.9 million USD |
| 2018 | -12.7 million USD | 6.0 million USD |
| 2017 | -36.6 million USD | 2.6 million USD |
NOVN
Price: $0.09
52 week price:
Earnings Per Share: 0.16 USD
P/E Ratio: -2.25
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 150500
Ebitda: -6.8 millionMarket Capitalization: 33.9 million